Insider Buying and Selling - RLMD

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
12/15/2025	12/16/2025	Shenouda Maged Chief Financial Officer CFO	Buy	11,665 @ $4.12	$48,059.80	800,000	(1.48%)	Direct
12/15/2025	12/16/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	27,500 @ $4.12	$113,300.00	1,300,000	(2.16%)	Direct
11/05/2025	11/06/2025	Ence Chuck CAO and COO Officer	Buy	136,000 @ $2.20	$299,200.00	403,931	(50.76%)	Direct
11/05/2025	11/06/2025	Kelly Paul Edward Chief Operating Officer Officer Director	Buy	90,000 @ $2.20	$198,000.00	502,295	(21.83%)	Direct
11/05/2025	11/06/2025	Shenouda Maged Chief Financial Officer CFO	Buy	500,000 @ $2.20	$1,100,000.00	788,335	(173.41%)	Direct
11/05/2025	11/06/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	272,500 @ $2.20	$599,500.00	1,272,500	(27.25%)	Direct
08/28/2025	08/28/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	55,976 @ $0.74	$41,422.24	1,000,000	(5.93%)	Direct
08/27/2025	08/28/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	129,455 @ $0.67	$86,734.85	944,024	(15.89%)	Direct
08/26/2025	08/28/2025	Traversa Sergio Chief Executive Officer CEO Director	Buy	80,545 @ $0.62	$49,937.90	814,569	(10.97%)	Direct

Relmada Therapeutics, Inc. - RLMD